Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermolysis Bullosa Dystrophica Dominans”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)UnknownNCT05529134
What this trial is testing

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Who this might be right for
Dystrophic Epidermolysis Bullosa
Phoenicis Therapeutics 8
Not applicableLooking for participantsNCT06563414
What this trial is testing

A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica Dominans
Krystal Biotech, Inc. 40
Large-scale testing (Phase 3)Study completedNCT04917874
What this trial is testing

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 47
Not applicableLooking for participantsNCT04917887
What this trial is testing

Long-Term Follow-up Protocol

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 50
Large-scale testing (Phase 3)Looking for participantsNCT07016750
What this trial is testing

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis BullosaDEB - Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa+1 more
Krystal Biotech, Inc. 16
Large-scale testing (Phase 3)Study completedNCT04491604
What this trial is testing

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT03605069
What this trial is testing

A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Who this might be right for
Epidermolysis Bullosa Dystrophica, RecessiveEpidermolysis Bullosa Dystrophica, Dominant
Phoenicis Therapeutics 2